Healios KK (HLOSF)
1.50
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Healios Profit Margin (Quarterly): -107.2% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -107.2% |
March 31, 2024 | -24.24K% |
December 31, 2023 | -24.73K% |
September 30, 2023 | -10.00K% |
June 30, 2023 | -660.0% |
March 31, 2023 | -10.46K% |
December 31, 2022 | -2.02K% |
September 30, 2022 | -8.70K% |
June 30, 2022 | -16.35K% |
March 31, 2022 | -13.27K% |
December 31, 2021 | -11.05K% |
September 30, 2021 | -16.39K% |
June 30, 2021 | -8.63K% |
March 31, 2021 | -11.43K% |
December 31, 2020 | -24.97K% |
September 30, 2020 | -20.07K% |
June 30, 2020 | -19.21K% |
March 31, 2020 | -18.04K% |
December 31, 2019 | -26.01K% |
Date | Value |
---|---|
September 30, 2019 | -14.49K% |
June 30, 2019 | |
March 31, 2019 | -859.6% |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | -2.63K% |
December 31, 2016 | -1.66K% |
September 30, 2016 | -2.86K% |
June 30, 2016 | -2.44K% |
March 31, 2016 | -10.32K% |
December 31, 2015 | -1.72K% |
September 30, 2015 | -955.1% |
June 30, 2015 | -448.3% |
March 31, 2015 | -1.22K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-26.01K%
Minimum
Dec 2019
-107.2%
Maximum
Jun 2024
-14.02K%
Average
-13.27K%
Median
Mar 2022
Profit Margin (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 7.83% |
Nxera Pharma Co Ltd | 12.95% |
PeptiDream Inc | 58.82% |
AnGes Inc | -2.95K% |
SanBio Co Ltd | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -137.2% |
Return on Assets | -33.10% |
Return on Invested Capital | -55.94% |
Gross Profit Margin (Quarterly) | 86.35% |
Operating Margin (Quarterly) | -56.63% |
Return on Net Operating Assets | -106.6% |